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aminocyclohexanes†
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Abstract
The syntheses of 12 stereochemically diverse polyhydroxyl aminocyclohexane (“aminocyclitols”) derivatives are
described. These short syntheses require 2–5 steps from N-(2,4-cyclohexadien-1-yl)phthalimide, which is
prepared in two steps from tricarbonyl(cyclohexadienyl)iron(1+). The relative stereochemistries of the
aminocyclitols were assigned by 1H NMR spectroscopy as well as X-ray diffraction analysis.

Introduction
Polyhydroxyl aminocyclohexanes (“aminocyclitols”, cf.Fig. 1) and derivatives are important biological entities.
For example, 2-deoxy-scyllo-inosamine (1) is an intermediate in the biosynthesis of deoxystreptamine, a
component of the aminoglycoside antibiotics,1 while the isomeric 5-amino-1,2,3,4cyclohexanetetraols 22 and 33 were found to be inhibitors of α-glucosidase and α-galactosidase (IC50 = 12.5 and
20 μM, respectively). Similarly, 1-amino-2,5-cyclohexanediols are structural components of potential antibiotics
such as 5.4 A variety of synthetic routes to aminocyclitols have been reported starting from quercitols
(deoxyinositols),2,3 from inositols via deoxygenation,5 from carbohydrates via Ferrier carbocyclic ringclosure,4,6via6-exo radical cyclization of carbohydrate derived oximes,7 and from chiral 1,7-octadienes viaringclosing metathesis.8 We herein report the de novo synthesis of a series of aminocyclitols from the readily
available9tricarbonyl(cyclohexadienyl)iron(1+) cation.

Fig. 1 Representative polyhydroxyl aminocyclohexanes.

Results and discussion
Reaction of tricarbonyl(cyclohexadienyl)iron(1+)6 with potassium phthalimide proceeded via attack at the dienyl
terminus to afford the complex (±)-7 (Scheme 1). Decomplexation of 7 with Ce4+ gave the free ligand N-(2,4cyclohexadien-1-yl)phthalimide, (±)-8. The structures of 7 and 8 were assigned on the basis of their NMR
spectral data. In particular, the 1H NMR signals for 7 at δ 2.77, 3.13, 5.53 and 5.67 ppm and the 13C NMR signals
at δ 57.1, 58.2, 86.0 and 86.7 ppm correspond to the hydrogens and carbons of an η4-bound cyclohexadiene
ligand.10 Similarly, the 1H NMR spectrum of 8 exhibits two signals for the diastereotopic methyleneprotons
at δ 2.38 and 2.78 ppm while the 13C NMR spectrum of 8 exhibits signals at δ 27.0 and 47.9 ppm corresponding
to the two sp3 hybridized carbons.

Scheme 1 Preparation of (cyclohexadienyl)phthalimide.
Cycloaddition of 8 with singlet oxygen gave a separable mixture of endoperoxides (±)-9 and (±)-10 (eqn (1)). The
relative stereochemistry of 9 and 10 were tentatively assigned by comparison of their 1H NMR spectral data. For
each, assignment of the signals for the diastereotopic methyleneprotons (H3 and H3′) was facilitated by the
magnitude of their vicinal couplings to H2; the syn-coupling (ca. 0° dihedral angle) is larger than the anti-coupling
(ca. 120° dihedral angle).11 The signal for H3′ of 9 appears upfield of that for 10, while the signal for
H3 of 9 appears downfield of that for 10. These relative chemical shifts are due to the anisotropic effect of the
olefin functionality. These tentative stereochemical assignments were eventually corroborated by single crystal
diffraction analysis of each.‡ The facial selectivity of this cycloaddition reaction (i.e. the major product
arises via approach on the face opposite to the phthalimide substituent), is similar to that previously reported
for the cycloaddition of nitrosobenzene and 3-methyl-5-phenyl-1,3-cyclohexadiene.12

(1)
Kornblum–DeLaMare rearrangement13 of 9 with DBU gave a mixture of 11–13 (eqn (2)). While
cyclohexenone13 could be obtained pure by chromatographic separation, the epimers 11 and 12 were only
characterized as a mixture. The structure of 13 was assigned by comparison of its NMR spectral data with that of
5-azido-4-(triisopropylsilyloxy)-2-cyclohexen-1-one.14 The structures of 11/12 were assigned on the basis of
their 1H NMR spectral data. In particular, the signals for the diastereotopic protons (H-6/H-6′) of 11 (δ 2.26 and
3.02 ppm) and 12 (δ 2.47 and 2.81 ppm) appear upfield of those for 13 (δ 2.67 and 3.43 ppm) while the signals
for H-1 of 11 (δ 5.34 ppm) and 12 (δ 4.98 ppm) appear downfield of the signal for H-1 of 13 (δ 4.65 ppm). These
relative chemical shifts are due to either the presence or absence of a neighboring carbonyl group. Furthermore,
the relative stereochemistry of the substitutents at C-1/C-5 of 11 (trans-) and 12 (cis-) were assigned on the
based on coupling patterns for H-6′; (11, dt, J = 3.6 and 13.2 Hz; 12, td, J = 11.4 and 14.4 Hz). The smaller doublet
coupling for 11 (compared to 12) is consistent with an axial–equatorial relative stereochemistry of H-5/H-6′ in
this structure.

(2)

The regioisomeric cyclohexenones arise due to deprotonation at either position adjacent to the
endoperoxide; i.e. deprotonation of H-1 results in the formation of 11/12 while deprotonation of H-4 (see eqn
(1)) results in formation of 13. The stereoisomers 11 and 12 presumably are the result of base catalyzed
epimerization α to the carbonyl; the diequatorial stereoisomer 12 being more stable than the axial–equatorial
stereoisomer 11.
Thioureareduction of 9 gave (±)-14 in good yield (Scheme 2), similarly reduction of 10 with thiourea gave (±)-15,
albeit in attenuated yield (40%). Alternative reduction conditions (Zn/HOAc,15aKI/HOAc/H2O,15b or
NaBH4/MeOH15c) did not result in improved yield. Reduction of 13 under Luche conditions16 gave (±)-16, while
reduction of the mixture of 11/12 gave a mixture of (±)-14, (±)-15 and (±)-16 (ca. 1 : 3 : 7 by 1H NMR integration).
Separation of this mixture by preparative TLC gave additional 16 (20%). The structures of 14–16 were assigned
on the basis of their 1H NMR spectral data. In particular, each of these N-(3-cyclohexen-1-yl)phthalimides is
anticipated to adopt a half-chair conformer in which the bulky phthalimide substituent occupies a pseudoequatorial orientation. The signals for the H-6axproton of 15 and 16 appear as a doublet of doublet of doublets
(15, J = 10.8, 12.8 and 14.4; 16, J = 10.0, 12.0 and 13.2). These three large couplings are due to the diaxial
relative orientations of H-6ax with respect to H-1 and H-5 in both 15 and 16 as well as the geminal coupling to H6eq). In comparison, the signal for H-6ax of 14 appears as a doublet of triplets (dt, J = 4.8 and 13.6); the smaller
coupling corresponds to the axial–equatorial relative orientation of H-6ax and H-5. The signals for H-1
of 14 and 16 appear as a doublet of doublet of doublets (14, J = 3.2, 10.0 and 13.6; 16, J = 3.0, 9.2 and 13.6);
the ca. 9–10 Hz coupling for each is indicative of a diaxial orientation of the H-1 and H-2protons.

Scheme 2 Preparation of stereoisomeric (2,5-dihydroxy-3-cyclohexen-1-yl)phthalimides.
Brief exposure (30 min) of (±)-8 to catalytic dihydroxylation conditions gave the diol (±)-17 (Scheme 3), whose
structure was tentatively assigned on the basis of its 1H NMR spectral data. In particular, the signal for the axial
H-6′proton of 17 appears at δ 2.35 ppm (ddd, J = 2.0, 10.2 and 13.6 Hz); the small coupling corresponds to the
axial–equatorial relative orientation of H-6′ and H-5. Reaction of 17 with acetic anhydride gave the diacetate (±)18. The relative configuration of 18 was assigned on the basis of single crystal X-ray diffraction,† which
consequently corroborated the structural assignment of 17. Dihydroxylation of 8 occurs more rapidly at the
olefin remote to the electron withdrawing phthalimide substituent.

Scheme 3 Dihydroxylation of (cyclohexadienyl)phthalimide8.

Catalyticreduction of 14, 15, 16 and 17 gave the saturated N-(dihydroxycyclohexyl)phthalimides (±)-19, (±)-20,
(±)-21, and (±)-22 (Scheme 4). The structures for diols 19–22 were assigned on the basis of the structures of each
precursor; the 1H NMR spectra for 19–22 are consistent with these assignments (vide infra).

Scheme 4 Hydrogenation and dihydroxylation of N-(dihydroxycyclohexenyl)phthalimides.
Osmium catalyzed dihydroxylation of 14 or 15 gave a single tetraol (±)-23 or (±)-24, while dihydroxylation of (±)17 gave (±)-26, albeit in low yield (Scheme 4). We attribute this lower yield to the diminished solubility of the
product under the reaction conditions. In comparison, dihydroxylation of the diacetate (±)-18 proceeds in
moderate yield; the product was characterized as the tetraacetate (±)-27. In contrast to these results,
dihydroxylation of 16, followed by peracetylation, gave a nearly equimolar mixture of tetraacetates (±)25a and b. The structural assignment for 26 was determined by single crystal X-ray diffraction analysis (Fig.
2)†‡ which indicated that the C-1 phthalimide and the C-2 and C-5 hydroxyls are equatorial and the C-3 and C5hydroxylgroups are axial. Tetraol23 was shown to be diastereomeric with 26 by NMR spectroscopy, and was
thus assigned a structure which is consistent with this relationship and consistent with syn-dihydroxylation. The
structures of 24, 25a, 25b and 27 were assigned on the basis of their 1H NMR spectral data and the
stereochemistry of their presursors (vide infra), and the structure of 25a was confirmed by single crystal X-ray
diffraction analysis (Fig. 3). In accord with the selectivity noted by Kishi, et al.,17 dihydroxylation
of 14 and 15 occurred preferentially on the face of the olefin opposite to the adjacent hydroxylgroups. In the
case of 16, the stereodirection effect of the two resident hydroxyls is mismatched, and thus a mixture of two
diastereomeric tetraacetates is isolated. For diol17 and diacetate18, dihydroxylation occurs on the face opposite
to phthalimide substitutent. It should be noted that the directing influence of the phthalimidegroup is greater
than that for the C-4hydroxylgroup.

Fig. 2 ORTEP of (±)-26 (arbitrary atomic numbering).

Fig. 3 ORTEP of (±)-25a (arbitrary atomic numbering).
Treatment of the major endoperoxide9 with Grubbs' 2nd generation catalyst,18 in the absense of any additional
olefin, proceeded rapidly with the complete disappearance of starting material (ca. 30 min). Analysis of the
crude product mixture by 1H NMR spectroscopy indicated this to be a mixture of Z-2-butendial, Nvinylphthalimide (28), oxetane (±)-29 and bisepoxide (±)-30 in a ratio of ca. 2 : 1.5 : 1 : 3 (Scheme 5). Purification
of this mixture by column chromatography gave 28, 29 and 30. While 2-butendial was not recovered after
chromatography, it was identified in the crude reaction mixture by comparison to its literature 1H NMR spectral
data.19N-Vinylphthalimide (28) was identified by comparison to its literature mp and NMR spectral data.20 The
structural assignment for 29 was based on its 1H NMR spectral data. In particular, signals at δ 10.15 (d, J = 7.2
Hz), 6.88 (ddd, J = 0.8, 6.8 and 11.5 Hz) and 6.07 ppm (dd, J = 7.2 and 11.6 Hz) correspond to the 3-oxo-1-Zbutenyl sidechain. The signals at 6.33 (q, J = 7.2 Hz) and 6.40 ppm (ddd, J = 1.2, 5.0 and 8.3 Hz) correspond to H3 and H-1 of the oxetane ring; similar chemical shifts have been reported for oxetane based nucleoside
analogs.21 The structural assignment for 30 was also based on its NMR spectral data. In particular, the four
relatively narrow one proton signals in the 1H NMR spectrum of 30 at δ 3.26, 3.30, 3.54–3.56 and 3.58–3.60 ppm
correspond to the four epoxide methine protons. These chemical shifts are similar to other cyclohexane
bisepoxides.22

Scheme 5 Ru-catalyzed rearrangement of 9.
The metal-mediated rearrangement of 1,4-epiperoxides (endoperoxides), including the use of Ru(ii) reagents,
has previously been reported.23 An inner-sphere radical mechanism may be proposed to account for formation
of the products 27–30 (Scheme 6). Complexation of a coordinatively unsaturated Ru(ii) species with 9, at the less
sterically hindered oxygen, generates 31. One electron exchange effects opening of the weak O–O bond to give
the oxyradical 32. Interaction with the double bond serves to generate the bisepoxide30. Alternatively, C–C
bond scission of 32 results in the nitrogen-stabilized radical species 33. Radical 33 may undergo further C–C
cleavage to generate 27 and 28, or reaction of the carbon radical at oxygen generates the oxetane ring 29. A
similar mechanism has been proposed to account for the formation of β-lactones from the keto endoperoxide of
phenol.24

Scheme 6 Proposed mechanism for Ru-catalyzed rearrangement of 9.
Allowing the crude product from the reaction of 9 with Grubbs' catalyst to stand on a column of silica gel
overnight led to the isolation of the epoxydiol (±)-33 (Scheme 7). This product presumably arises via selective
hydrolysis of the bisepoxide30. Treatment of 14 or 17 with mCPBA gave a single epoxide in each case [(±)-34 or
(±)-35, respectively, Scheme 7]. The structural assignments for 33–35 are based on single crystal X-ray diffraction
analysis of each.†‡ Notably, 34 and 35 arise viaepoxidation on the same face of the olefin as the adjacent
hydroxylgroup.25Hydrolysis of 33 gave tetraol (±)-24, while hydrolysis/acetoxylation of 35 gave tetraacetate (±)-

36. In contrast, hydrolysis/acetoxylation of 34 gave a mixture of diastereomeric tetraacetates (±)-37 and (±)38 (ca. 2 : 1 ratio by 1H NMR integration). Separation of the mixture of 37/38 was aided by slow recrystallization
from ethyl acetate. The two distinct crystalline forms were manually separated by tweezers. Tetraol24 was
identified by comparison of its spectral data with the sample prepared by dihydroxylation of 15 (vide supra). The
products 36–38 are based on their NMR spectral data (vide infra); and the assignments for 37 and 38 were
corroborated by single crystal X-ray diffraction analysis of each (Fig. 4 and 5, respectively).†‡ The
products 24, 36 and 38 arise by a diaxial ring opening of the epoxide ring, while hydrolysis/acetoxylation
of 34via a diequatorial, boat-like transition state leads to 37.

Scheme 7 Generation of aminocyclitol tetraacetates viaepoxidation and hydrolysis.

Fig. 4 ORTEP of (±)-37 (arbitrary atomic numbering).

Fig. 5 ORTEP of (±)-38 (arbitrary atomic numbering).
The structural assignments for many of the polyhydroxyl cyclohexylphthalimides are based on their 1H NMR
spectral data. In particular, for those compounds in which the C-1 phthalimide and the C-5hydroxyl/acetoxy
are cis (i.e. diequatorial; 20, 21, 24 and 25a/b) the signal for H-6ax appears as either a quartet (J∼ 12 Hz) or as a
doublet of triplets (J = 10.9 and 12.9). Conversely, for those compounds in which the C-1 phthalimide and the C5hydroxyl/acetoxy are trans (19, 23, 26, 27, 36, 37 and 38), the signal for H-6ax appears as a doublet (J∼ 2.4) of
triplets (J∼ 13). For structures in which the C-1 phthalimide and the C-2hydroxyl/acetoxy
are trans (i.e. diequatorial; 19, 21, 25a/b, 27, 37 and 38) the signal for H-1 appears as either a doublet of doublet
of doublets (J∼ 4.5, 10.5 and 13 Hz) or as a doublet (J∼ 4.2) of triplets (J∼ 12). Conversely, for those compounds
in which the C-1 phthalimide and the C-2hydroxyl/acetoxy are cis the signal for H-1 appears as a broad doublet
(20, J = 14) or a doublet of doublet of doublets (24 or 36; J∼ 3, 4 and 13 Hz). For the tetraacetates in which H-2 is
axial (25a, 25b, 37 or 38), the magnitude of the coupling between H-2 and H-3 allows for assignment of their
relative stereochemistry (diaxial, JH2–H3∼ 10 Hz; axial–equatorial, JH2–H3∼ 3–4 Hz). Similarly, for tetraols or
tetraacetates in which H-5 is axial (24, 25a, 25b), the stereochemistry of the C-4 substitutent may be assigned
axial or equatorial based on the magnitude of the coupling between H-4 and H-5.

Conclusions
By sequential oxidation (1O2, dihydroxylation and/or epoxidation), rearrangement, reduction, or hydrolysis
reactions, a single (cyclohexadienyl)phthalimide can be used to prepare a series of stereochemically diverse
polyhydroxy aminocyclohexanes. The structural assignments of these products are based on their NMR spectral
data as well as X-ray diffraction in certain cases.

Experimental
General methods

All reactions involving moisture or air sensitive reagents were carried out under an nitrogen atmosphere in
oven-dried glassware with anhydrous solvents. Purifications by chromatography were carried out using silica gel
60 (40–63 μm). NMR spectra were recorded on either a Varian Mercury+ 300 MHz or a Varian UnityInova 400
MHz instrument. CDCl3, CD3OD, d6-acetone and d6-DMSO were purchased from Cambridge Isotope
Laboratories. 1H NMR spectra were calibrated to 7.27 ppm for residual CHCl3, 3.31 ppm for CD2HOD, 2.05 ppm
for d5-acetone or 2.50 ppm for d5-DMSO. 13C NMR spectra were calibrated from the central peak at 77.23 ppm
for CDCl3, 49.15 ppm for CD3OD, 29.92 ppm for d6-acetone or 39.51 for d6-DMSO. Coupling constants are

reported in Hz. Elemental analyses were obtained from Midwest Microlabs, Ltd., Indianapolis, IN, and highresolution mass spectra were obtained from the University of Nebraska Center for Mass Spectrometry.

Tricarbonyl-(5-phthalimido-1,3-cyclohexadiene)iron (±)-7

To a solution of 6 (920 mg, 2.95 mmol) in dry CH2Cl2 (40 mL), at room temperature under N2, was added solid
potassium phthalimide (820 mg, 4.43 mmol). The mixture was stirred for 5 h, and then quenched with water and
extracted several times with CH2Cl2. The combined extracts were washed with brine, dried (Na2SO4) and
concentrated. The residue was purified by column chromatography (SiO2, hexane–ethyl acetate = 6 : 1) to afford
(±)-7 (807 mg, 75%) as a light yellow solid (Found: C, 56.10; H, 3.18. Calcd for C17H11O5Fe: C, 55.92; H, 3.04.); mp
166–169 °C; δH (400 MHz, CDCl3) 2.00 (1H, br d, J = 15.1 Hz, H-6α), 2.31 (1H, ddd, J = 4.2, 11.4 and 15.1, H-6β),
2.77 (1H, ddd, J = 1.0, 3.2 and 6.3, H-4), 3.15–3.11 (1H, m, H-1), 4.80 (1H, td, J = 3.7 and 11.5, H-5), 5.53 (1H,
t, J = 5.6, H-3), 5.67 (1H, t, J = 5.7, H-4) and 7.60–7.83 (4H, m, Phth); δC (100 MHz, CDCl3) 27.3 (C-6), 48.1 (C-5),
57.1, 58.2 (C-1, C-4), 86.0, 86.7 (C-2, C-3), 123.3, 132.1, 134.2 (3 × Phth), 168.2 (N–C O) and 211.4 (M–CO).

N-(2,4-Cyclohexadien-1-yl)phthalimide (±)-8

To a stirring solution of iron complex 7 (800 mg, 2.19 mmol) in methanol (110 mL) was added solid ceric
ammonium nitrate (360 mg, 6.56 mmol). The mixture was stirred for 2 h and then quenched with water and
extracted several times with CH2Cl2. The combined extracts were washed with brine, dried (Na2SO4) and
concentrated. The residue was purified by column chromatography (SiO2, hexane–ethyl acetate = 4 : 1) to give
(±)-8 (400 mg, 81%) as a colorless solid (Found: C, 74.60; H, 4.94; N, 6.24. Calcd for C14H11O2: C, 74.65; H, 4.92; N,
6.22); mp 138–140 °C; δH (400 MHz, CDCl3) 2.38 (1H, ddd, J = 5.6, 10.0 and 17.2, H-6), 2.78 (1H, tdd, J = 3.1, 15.2
and 17.6, H-6′), 5.20 (1H, tdd, J = 2.9, 9.6 and 15.2, H-1), 5.68 (1H, dd, J = 3.0 and 9.6, CH CH), 5.89–6.10 (3H, m,
CH CH) and 7.71–7.86 (4H, m, Phth); δC (100 MHz, CDCl3) 27.5 (C-6), 45.9 (C-1), 123.2 (Phth), 123.7, 125.3,
125.5, 125.6 (C-2, C-3, C-4, C-5), 132.1, 133.9 (2 × Phth) and 176.2 (N–C O).

Singlet oxygencycloaddition

To a 100 mL two-necked round-bottomed flask, equipped with a condenser, was added a solution of (±)-8 (1.00
g, 4.44 mmol) in CHCl3 (16 mL) and tetraphenylporphine (138 mg, 5 mol%). The deep purple solution was stirred
at 0 °C and irradiated with a 60 W tungsten-halogen lamp for 8 h while ultrapure O2 was bubbled through the
solution. The reaction mixture was concentrated under reduced pressure and the residue purified by column
chromatography (SiO2, hexane–ethyl acetate = 4 : 1) to give (±)-9 (593 mg, 52%) as a colorless solid. Further
elution (hexane–ethyl acetate = 3 : 1) gave (±)-10 (201 mg, 18%) as a colorless solid.

N-(8,9-Dioxobicyclo[2.2.2]oct-5-en-2-yl)phthalimide (±)-9

(Found: C, 65.45; H, 4.39. Calcd for C14H11NO4: C, 65.36; H, 4.31); mp 155–157 °C; δH (400 MHz, CDCl3) 2.42 (1H,
ddd, J = 2.0, 4.4 and 13.6, H-3), 2.80 (1H, ddd, J = 4.0, 9.6 and 13.6, H-3′), 4.84–4.98 (3H, m, H-1, H-2 and H-4),
6.65 (1H, ddd, J = 1.6, 6.0 and 8.0, CH CH), 6.88 (1H, ddd, J = 1.6, 6.0 and 8.0, CH CH), 7.71–7.74 and 7.79–7.83
(4H total, AA′BB′, Phth); δC (100 MHz, CDCl3) 28.5 (C-3), 45.9 (C-2), 71.2 (C-1 or C-4), 123.5, 129.5, 131.6, 134.0,
134.5 (CH CH and Phth), and 168.3 (N–C O); one peak obscured by solvent.

N-(8,9-Dioxobicyclo[2.2.2]oct-5-en-2-yl)phthalimide (±)-10

(Found: C, 65.46; H, 4.34. Calcd for C14H11NO4: C, 65.36; H, 4.31); mp 235–240 °C; δH (300 MHz, CDCl3) 1.88 (1H,
ddd, J = 1.9, 11.8 and 13.8, H-3), 3.64 (1H, td, J = 4.2 and 13.8, H-3′), 4.41 (1H, ddd, J = 1.8, 4.5 and 12.0, H-2),
4.67 (1H, qd, J = 1.7 and 6.3, H-1), 4.89 (1H, qdd, J = 1.8, 3.6 and 5.7, H-4), 6.75–6.87 (2H, m, H-5 and H-6), 7.70–
7.74 and 7.78–7.83 (4H total, AA′BB′, Phth); δC (75 MHz, CDCl3) 21.0 (C-3), 47.2 (C-2), 70.9, 75.2 (C-1, C-4), 123.5,
130.8, 132.0, 134.0, 134.3 (C-5, C-6 and Phth) and 168.9 (N–C O).

N-(5-Hydroxy-2-oxo-3-cyclohexen-1-yl)phthalimide11/12 and N-(2S*-hydroxy-5-oxo-3cyclohexen-1S*-yl)phthalimide (±)-13

To a solution of cyclic peroxide9 (690 mg, 2.68 mmol) in dry CH2Cl2 (25 mL) at room temperature was added
dropwise 1,8-diazabicyclo[5.4.0]undec-7-ene (0.70 mL, 4.0 mmol). The mixture was stirred for 15 min, diluted
with additional CH2Cl2 (20 mL), neutralized with amberlite IRC–76, filtered and concentrated. Purification of the
residue by column chromatography (SiO2, hexane–ethyl acetate = 1 : 1) gave (±)-13 (278 mg, 40%) as a colorless
solid, followed by a mixture of 11/12 (164 mg, 24%, mp 192–195 °C) as a colorless solid.
(±)-13: (Found: C, 65.01; H, 4.31. Calcd for C14H11NO4: C, 65.36; H, 4.31); mp 175–177 °C; δH (400 MHz, CDCl3)
2.67 (1H, dd, J = 4.8 and 16.4, H-6eq), 3.43 (1H, dd, J = 13.6 and 16.4, H-6ax), 4.65 (1H, ddd, J = 4.8, 10.0 and 14.0,
H-1), 5.33 (1H, br d, J = 10.4, H-2), 6.11 (1H, d, J = 10.0, H-4), 7.02 (1H, dd, J = 1.6 and 10.0, H-3) and 7.78–7.89
(4H, m, Phth); δC (75 MHz, CDCl3) 40.2 (C-6), 53.6 (C-1), 67.7 (C-2), 123.8 (Phth), 129.6 (C-4), 131.8, 134.6 (2 ×
Phth), 152.3 (C-3), 168.5 (N–C O) and 196.4 (C O).
12: δH (400 MHz, CD3OD) 2.43–2.51 (1H, m, H-6), 2.81 (1H, td, J = 11.4 and 14.4, H-6′), 4.75–4.84 (1H, m, H-5),
4.98 (1H, dd, J = 5.0 and 14.6, H-1), 6.09 (1H, dd, J = 2.4 and 10.8, H-3), 7.12 (1H, d, J = 10.4, H-4) and 7.78–7.96
(m, 4H, Phth).
11: δH (partial, 400 MHz, CD3OD) 2.26 (1H, br d, J = 13.2, H-6), 3.02 (1H, dt, J = 3.6 and 13.2, H-6′), 4.58–4.60 (1H,
m, H-5) and 5.35 (1H, dd, J = 4.8 and 13.2, H-1).

N-(2R*,5S*-Dihydroxy-3-cyclohexen-1S*-yl)phthalimide (±)-14

To a solution of 9 (25 mg, 0.097 mmol) in methanol (1.5 mL) at room temperature under nitrogen was added
solid thiourea (7.0 mg, 0.097 mmol). The mixture was stirred for 15 h, then concentrated under vacuum and the
residue purified by column chromatography (SiO2, hexane–ethyl acetate = 3 : 1) to afford (±)-14 (19 mg, 75%) as
a colorless solid (Found: C, 64.92; H, 5.11. Calcd for C14H13NO4: C, 64.86; H, 5.05); mp 180–183 °C; δC (400 MHz,
CDCl3) 1.97 (1H, br d, J = 14.0, H-6eq), 2.28 (1H, br s, OH), 2.35 (1H, br s, OH), 2.82 (1H, dt, J = 4.8 and 13.6, H-6ax),
4.42 (1H, br s, H-5), 4.58 (1H, ddd, J = 3.2, 10.0 and 13.6, H-1), 4.84 (1H, br d, J = 9.2, H-2), 5.92 (2H, narrow m,
CH CH), 7.70–7.74 and 7.81–7.85 (4H total, AA′BB′, Phth); δC (100 MHz, CD3OD) 35.1 (C-6), 51.5, 65.2, 68.5 (C-1,
C-2 and C-5), 124.1, 130.1, 133.5, 134.8, 135.4 (CH CH and Phth) and 170.2 (N–C O).

N-(2S*,5R*-Dihydroxy-3-cyclohexen-1S*-yl)phthalimide (±)-15

Cyclic peroxide10 (0.10 g, 0.40 mmol) was reduced with thiourea in a fashion similar to the preparation of 14.
The reaction mixture was concentrated under vacuum and the residue was purified by column chromatography
(SiO2, hexane–ethyl acetate = 1 : 4) to give (±)-15 (40 mg, 40%) as a colorless solid (Found: C, 64.77; H, 5.08.
Calcd for C14H13NO4: C, 64.86; H, 5.05); mp 167–174 °C; δH (400 MHz, CDCl3) 2.21 (1H, br d, J = 12.8, H-6eq), 2.26
(1H, d, J = 7.2, OH), 2.81 (1H, d, J = 8.8, OH), 2.85 (1H, ddd, J = 10.8, 12.8 and 14.4, H-6ax), 4.17–4.23 (1H, m),
4.43–4.45 (2H, m), 5.96–5.97 (2H, narrow m, CH CH), 7.70–7.74 and 7.81–7.85 (4H total, AA′BB′, Phth); δC (100
MHz, CD3OD) δ 31.2 (C-6), 52.7, 65.8, 69.1 (C-1, C-2, C-5), 124.1, 128.2, 133.4, 135.4, 136.8 (CH CH and Phth)
and 170.4 (N–C O).

N-(2R*,5R*-Dihydroxy-3-cyclohexen-1S*-yl)phthalimide (±)-16

To a solution of 13 (270 mg, 1.05 mmol) in methanol (6 mL) was added CeCl3·7H2O (391 mg, 1.05 mmol)
followed by NaBH4 (80 mg, 2.1 mmol). The reaction mixture was stirred for 45 min and then quenched with
water. The mixture was extracted several times with ethyl acetate and the combined organic layers were
washed with saturated aqueous NaHCO3, dried (Na2SO4) and concentrated. Purification of the residue by column
chromatography (SiO2, hexane–ethyl acetate = 1 : 1) gave (±)-16 (167 mg, 61%) as a colorless solid (Found: C,
64.93; H, 5.27. Calcd for C14H13NO4: C, 64.86; H, 5.05); mp 187–190 °C; δH (400 MHz, CD3OD) 2.09–2.15 (1H, m,

H-6eq), 2.46 (1H, ddd, J = 10.0, 12.0 and 13.2, H-6ax), 4.19 (1H, ddd, J = 3.0, 9.2 and 13.6, H-1), 4.39–4.46 (1H, m),
4.85–4.95 (1H, m), 5.73 (1H, td, J = 1.6 and 10.4, CH CH), 5.78 (1H, qd, J = 1.9 and 10.4, CH CH) and 7.78–7.89
(4H, m, Phth); δC (75 MHz, d6-acetone) 36.8 (C-6), 54.5 (C-1), 67.5, 67.7 (C-2 and C-5), 123.7, 131.8, 133.1, 134.0,
135.0 (CH CH and Phth) and 169.0 (N–C O).

N-(4R*,5S*-Dihydroxy-2-cyclohexen-1S*-yl)phthalimide (±)-17

To a solution of diene 8 (750 mg, 3.33 mmol) in acetone (15 mL) was added a solution of N-methylmorpholine Noxide (960 mg, 8.19 mmol) in water (4 mL) followed by a solution of OsO4 in toluene (2 mL, 10 mol%). The
reaction mixture was stirred for 30 min at room temperature and then solid Na2S2O4 (0.6 g) was added and
stirring continued for another 30 min. The crude reaction mixture was adsorbed on silica gel, applied to the top
of a chromatography column and purified (hexane–ethyl acetate = 1 : 4) to give (±)-17 (447 mg, 52%) as a
colorless solid (Found: C, 64.87; H, 5.02. Calcd for C14H13NO4: C, 64.86; H, 5.05); mp 178–181 °C; δH (400 MHz,
CD3OD) 2.12 (1H, dtd, J = 1.6, 5.8 and 13.4, H-6eq), 2.35 (1H, ddd, J = 2.0, 10.2 and 13.6, H-6ax), 4.17–4.22 (1H, m),
4.30–4.34 (1H, m), 5.11–5.17 (1H, m), 5.63 (1H, dtd, J = 1.6, 2.4 and 10.2, CH CH), 5.73 (1H, dt, J = 1.6, 2.0 and
10.4, CH CH) and 7.78–7.85 (4H, m, Phth); δC (100 MHz, CD3OD) δ 33.4 (C-6), 45.4 (C-1), 68.6, 69.5 (C-4, C-5),
124.2 (Phth), 129.1 (CH CH), 131.9, 133.4 (2 × Phth), 135.5 (CH CH), and 169.6 (N–C O).

N-(4R*,5S*-Diacetoxy-2-cyclohexen-1S*-yl)phthalimide (±)-18

To a suspension of diol17 (30 mg, 0.12 mmol) in CH2Cl2 (0.8 mL), at room temperature, was added dropwise
pyridine (0.10 mL, 1.2 mmol). Upon addition of pyridine the mixture became clear. Acetic anhydride (0.10 mL,
1.2 mmol) was added and the resultant mixture was stirred for 12 h. The reaction mixture was quenched with 1
M HCl (5 mL) and extracted several times with CH2Cl2. The combined extracts were washed with brine, dried
(Na2SO4) and concentrated. The residue was purified by column chromatography (SiO2, hexane–ethyl acetate =
1 : 1) to afford (±)-18 (27 mg, 68%) as a colorless solid (Found: C, 63.64; H, 5.12. Calcd for C18H17NO6: C, 62.97; H,
4.99); mp 151–154 °C; δH (300 MHz, CDCl3) 2.07 (3H, s, OAc), 2.15 (3H, s, OAc), 2.19–2.28 (1H, m, H-6eq), 2.54
(1H, ddd, J = 2.1, 9.3 and 13.8 Hz, H-6ax), 5.17 (1H, ddd, J = 2.9, 6.3 and 9.3 Hz, H-1), 5.62–5.67 and 5.68–5.72
(2H, 2 × m, H-4 and H-5), 5.78 (2H, s, H-2 and H-3), 7.72–7.77 and 7.82–7.88 (4H total, AA′BB′, Phth); δC (75 MHz,
CDCl3) 21.1 and 21.3 (2 ×CH3CO2), 30.0 (C-6), 44.1 (C-1), 67.9, 68.3 (C-4 and C-5), 123.6, 127.1 (2 × Phth), 129.9
(CH CH), 132.0 (Phth), 134.4 (CH CH), 168.0 (N–C O), 170.4 and 170.7 (2 × CH3CO2).

N-(2R*,5R*-Dihydroxycyclohex-1S*-yl)phthalimide (±)-19

A solution of 14 (0.20 g, 0.77 mmol) in methanol (20 mL), containing a suspension of 10% Pd/C (60 mg) was
stirred under H2 (40 psi) for 5 h. After releasing the excess H2 pressure, the reaction mixture was filtered through
Celite. The filtrate was concentrated, adsorbed to silica and applied to a column of silica. Elution (hexane–ethyl
acetate = 1 : 4) gave (±)-19 (143 mg, 76%) as a colorless solid (Found: C, 64.20; H, 5.73. Calcd for C14H15NO4: C,
64.36; H, 5.79); mp 198–200 °C; δH (400 MHz, CD3OD) 1.60–1.72 (1H, m), 1.84–1.91 (4H, m), 2.42 (1H, dt, J = 2.4
and 13.2, H-6ax), 4.14 (1H, pent, J = 2.6, H-5), 4.26 (1H, dt, J = 6.4 and 9.8, H-2), 4.47 (1H, ddd, J = 4.0, 10.0 and
12.8, H-1) and 7.75–7.88 (4H, m, Phth); δC (100 MHz, CD3OD) δ 29.8, 31.9, 36.3 (C-3, C-4 and C-6), 53.5 (C-1),
66.7, 70.2 (C-2 and C-5), 124.0, 133.5, 135.3 (3 × Phth), 170.3 (N–C O).

N-(2S*,5S*-Dihydroxycyclohex-1S*-yl)phthalimide (±)-20

The reduction of 15 (40.0 mg, 0.154 mmol) in methanol (7 mL) with H2 (40 psi) catalyzed by 10% Pd/C (ca. 5 mg)
was carried out in a fashion similar to the reduction of 14. Purification of the residue by column chromatography
(hexane–ethyl acetate = 1 : 4) gave (±)-20 (25 mg, 62%) as a colorless solid (Found: C, 62.03; H, 5.70. Calcd for
C14H15NO4·½H2O: C, 62.21; H, 5.96); mp 175–177 °C; δH (300 MHz, CD3OD) 1.60–1.95 (5H, m, H-3, H3′, H-4, H4′,
H6eq), 2.88 (1H, td, J = 11.7 and 13.5, H-6ax), 3.60–3.72 (1H, m), 3.98 (1H, br s), 4.18 (1H, ddd, J = 2.2, 3.8, 13.5)

and 7.75–7.90 (4H, m, Phth); δC (100 MHz, CD3OD) δC 29.5, 30.4, 33.6 (C-3, C-4, C-6), 55.4 (C-1), 68.5, 70.8 (C-2
and C-5), 124.2, 133.3, 135.5 (Phth) and 170.6 (N–C O).

N-(2R*,5S*-Dihydroxycyclohex-1S*-yl)phthalimide (±)-21

The reduction of 16 (56.0 mg, 0.216 mmol) in methanol (10 mL) with H2 (40 psi) catalyzed by 10% Pd/C (ca. 5
mg) was carried out in a fashion similar to the reduction of 14. Filtration of the reaction mixture through Celite
and concentration of the filtrate gave (±)-21 (36 mg, 64%) as a colorless solid (Found: C, 64.01; H, 5.76. Calcd for
C14H15NO4: C, 64.36; H, 5.76); mp 243–245 °C; δH (300 MHz, CD3OD) 1.38–1.55 (2H, m), 1.93–2.18 (3H, m), 2.25
(1H, q, J = 12.0, H-6ax), 3.64–3.76 (1H, m), 4.02 (1H, ddd, J = 4.4, 9.3 and 13.5, H-1), 4.21–4.31 (1H, m), 7.78–7.90
(4H, m, Phth); δC (75 MHz, CD3OD) δ 32.4, 34.3, 38.2 (C-3, C-4, C-6), 55.9 (C-1), 69.6, 70.0 (C-2 and C-5), 124.1,
133.4, 135.4 (Phth), 170.1 (N–C O).

N-(3S*,4R*-Dihydroxycyclohex-1R*-yl)phthalimide (±)-22

The reduction of 17 (0.10 g, 0.38 mmol) in methanol (10 mL) with H2 (40 psi) catalyzed by 10% Pd/C (ca. 5 mg)
was carried out in a fashion similar to the reduction of 14. Purification by column chromatography (SiO2,
hexane–ethyl acetate = 1 : 4) gave (±)-22 (75 mg, 74%) as a colorless solid; mp 243–245 °C; δH (300 MHz,
CD3OD) δ 1.60–1.80 (2H, m), 1.84–1.96 (2H, m), 2.28 (1H, dq, J = 4.2 and 13.0, H-2ax), 2.52 (1H, dt, J = 2.4 and
12.8, H-2ax), 3.67 (1H, ddd, J = 2.9, 4.5 and 11.5, H-4), 4.03–4.07 (1H, narrow m, H-3), 4.58 (1H, tt, J = 4.1 and
12.8, H-1) and 7.75–7.88 (4H, m, Phth); δC (100 MHz, d6-DMSO) δ 27.3, 27.6, 34.3 (C-2, C-5, C-6), 44.3 (C-1), 68.6,
70.2 (C-3 and C-4), 122.9, 131.5, 134.3 (Phth), 168.0 (N–C O); FAB-HRMS calcd for C14H15NO4Li (M+Li+) 268.1161,
found 268.1157.

N-(2R*,3S*,4R*,5S*-Tetrahydroxycyclohex-1S*-yl)phthalimide (±)-23

To a stirring solution of 14 (60 mg, 0.23 mmol) in acetone (1 mL) was added a solution of Nmethylmorpholine N-oxide (70 mg, 0.58 mmol) in water (0.3 mL) followed by a solution of OsO4 in toluene (0.1
mL, 10 mol%). The reaction mixture was stirred for 20 h at room temperature and then Na2S2O4 (35 mg) was
added and stirred for another 30 min. The mixture was concentrated, adsorbed to silica using methanol and
purified by column chromatography (SiO2, CH2Cl2–methanol = 9 : 1) to give (±)-23 (42 mg, 62%) as a colorless
solid (Found: C, 57.29; H, 5.34. Calcd for C14H15NO6: C, 57.33; H, 5.15); mp 267–270 °C; δH (400 MHz, CD3OD) 1.69
(1H, td, J = 2.8 and 13.2, H-6eq), 2.82 (1H, dt, J = 2.8 and 13.2, H-6ax), 3.73 (1H, dd, J = 3.2 and 9.6, H-3), 3.93–4.00
(2H, m, H-4 and H-5), 4.43–4.50 (2H, m, H-1 and H-2) and 7.78–7.87 (4H, m, Phth); δC (100 MHz, CD3OD) 31.2 (C6), 51.6 (C-1), 70.4, 70.7, 74.0, 74.4 (C-2, C-3, C-4 and C-5), 124.1, 133.5, 135.4 (3 × Phth) and 170.2 (N–C O).

N-(2S*,3R*,4S*,5R*-Tetrahydroxycyclohex-1S*-yl)phthalimide (±)-24

The dihydroxylation 15 (30.0 mg, 0.115 mmol) with catalytic OsO4 and NMO was carried out in a fashion similar
to the dihydroxylation of 14. Purification of the residue by column chromatography (SiO2, ethyl acetate) gave
(±)-24 (20 mg, 59%) as a colorless solid (Found: C, 57.53; H, 5.11. Calcd for C14H15NO6: C, 57.33; H, 5.15); mp
253–255 °C; δH (400 MHz, CD3OD) 1.89 (1H, td, J = 3.8 and 12.4, H-6eq), 2.86 (1H, q, J = 12.4, H-6ax), 3.71 (1H,
dd, J = 2.8 and 9.6, H-4), 3.82 (1H, ddd, J = 4.8, 10.0 and 11.6, H-5), 3.94–3.99 (2H, m, H-2 and H3), 4.69 (1H,
ddd, J = 2.0, 4.4 and 14.0, H-1) and 7.78–7.87 (4H, m, Phth); δC (100 MHz, CD3OD) δ 31.3 (C-6), 50.1 (C-1), 70.5,
74.0, 74.1, 74.2 (C-2, C-3, C-4 and C-5), 124.2, 133.3, 135.5 (3 × Phth) and 170.7 (N–C O).

N-(2S*,3S*,4R*,5S*-Tetraacetoxycyclohex-1R*-yl)phthalimide (±)-25a and N(2S*,3R*,4S*,5S*-tetraacetoxycyclohex-1R*-yl)phthalimide (±)-25b

The dihydroxylation of 16 (160 mg, 0.620 mmol) with catalytic OsO4 and NMO was carried out in a fashion
similar to the dihydroxylation of 14. Purification of the crude product (SiO2, ethyl acetate–methanol = 9 : 1) gave
a mixture of two tetraols (82 mg) as a colorless solid. The mixture (82 mg, 0.27 mmol) was suspended in acetic

anhydride (0.6 mL) at room temperature and pyridine (0.4 mL) was added dropwise. After stirring overnight, the
reaction mixture was diluted with ethyl acetate and quenched with 1 M HCl (7 mL). The mixture was extracted
several times with ethyl acetate and the combined extracts were washed with brine, dried (Na2SO4) and
concentrated. Purification of the residue by column chromatography (SiO2, hexane–ethyl acetate = 1 : 1) gave a
mixture of (±)-25a and (±)-25b (ca. 9 : 11 by 1H NMR integration) (104 mg, 36%) as a colorless solid (Found: C,
57.27; H, 5.03. Calcd for C22H23NO10: C, 57.26; H, 5.02); mp 150–160 °C; δH (400 MHz, CDCl3) (13H, 8×s and 2×m,
H-6 and OAc for a and b), 2.56 (0.45H, dt, J = 10.9 and 12.9, H-6ax25a), 3.14 (0.55H, q, J = 12.7, H-6ax25b), 4.40
(0.55H, ddd, J = 4.8, 10.4 and 13.6, H-1 25b), 4.77 (0.45H, ddd, J = 4.8, 11.0 and 13.4, H-1 25a), 5.04 (0.55H,
ddd, J = 2.0, 4.4 and 12.0, H-525b), 5.07 (0.55H, dd, J = 2.8 and 10.4, H-325b), 5.24-5.22 (0.45H, dd, J = 2.6 and
10.2, H-425a), 5.33 (0.45H, m, H-525a), 5.63 (0.55H, narrow m, H-425b), 5.71 (0.45H, t, J = 2.8, H-325a), 5.77
(0.45H, dd, J = 2.6 and 11.0, H-225a), 5.92 (0.55H, t, J = 10.4, H-225b), 7.70–7.88 (4H, m, Phth).

N-(2S*,3S*,4R*,5R*-Tetrahydroxycyclohex-1R*-yl)phthalimide (±)-26

The dihydroxylation 17 (100 mg, 0.380 mmol) with catalytic OsO4 and NMO was carried out in a fashion similar
to the dihydroxylation of 14. Purification of the residue by column chromatography (SiO2, methanol–CH2Cl2 =
1 : 4, few drops of NH4OH) gave (±)-26 (22 mg, 21%) as a colorless solid. mp 243–245 °C; δH (d6-DMSO, 300
MHz) δ 1.79 (1H, td, J = 3.6 and 13.2, H-6eq), 2.19 (1H, dt, J = 1.8 and 13.2, H-6ax), 3.46 (1H, td, J = 2.7 and 6.3, H6), 3.86–3.96 (2H, br m), 4.02–4.10 (1H, br m), 4.55 (1H, dt, J = 4.2 and 12.0, H-1), 4.84–4.94 (3H, m, 3 × OH),
5.03 (1H, d, J = 5.7, OH) and 7.80–7.92 (4H, m, Phth); δC (75 MHz, d6-DMSO) 32.4 (C-6), 46.5 (C-1), 68.3, 69.2,
70.4, 75.3 (C-2, C-3, C-4, C-5), 122.8, 131.6, 134.3 (3 × Phth) and 168.4 (N–C O); FAB-HRMS calcd for C14H15NO6Li
(M+Li+) 300.1059, found 300.1067.

N-(2S*,3S*,4R*,5R*-Tetraacetoxycyclohex-1R*-yl)phthalimide (±)-27

The dihydroxylation of diacetate18 (60 mg, 0.17 mmol) with catalytic OsO4 and NMO was carried out in a fashion
similar to the dihydroxylation of 14. Purification of the residue by column chromatography (SiO2, hexanes–ethyl
acetate = 1 : 4) gave a mixture of diol-diacetates as a colorless solid (44 mg, 67%). Acetoxylation of the crude
product (40 mg, 0.11 mmol) with acetic anhydride and pyridine was carried out in a fashion similar to the
acetoxylation of 17. Purification of the residue by column chromatography (SiO2, hexanes–ethyl acetate = 1 : 1)
gave a (±)-27 as a colorless solid (26 mg, 51%). (Found: C, 56.86; H, 5.10. Calcd for C22H23NO10: C, 57.26; H, 5.04);
mp 165–167 °C; δH (CDCl3, 400 MHz) δ 1.79 (3H, s, OAc), 1.97 (3H, s, OAc), 1.96–2.05 (1H, m, H-6eq), 2.12 (3H, s,
OAc), 2.16 (3H, s, OAc), 2.76 (1H, br t, J = 14.0, H-6ax), 4.90 (1H, dt, J = 4.2 and 12.2, H-1), 5.11 (1H, br s), 5.45
(1H, br s), 5.64–5.74 (2H, m) and 7.78–7.85 (4H, m, Phth); δC (100 MHz, CDCl3) 20.6, 20.7, 21.0, 21.2 (4 ×CH3CO2),
29.6 (C-6), 44.3 (C-1), 67.5, 68.3, 68.5, 69.3 (C-2, C-3, C-4 and C-5), 123.7, 131.6, 134.5 (3 × Phth), 168.1, 169.6,
169.7, 170.2, 170.4 (5 × C O).

Reaction of endoperoxide with Grubbs' catalyst

To a solution of endoperoxide (±)-9 (50 mg, 0.19 mmol) in dry CH2Cl2 (1.5 mL), at room temperature, was added
Grubbs' II catalyst (1.6 mg, 10 mol%). The mixture was stirred for 30 min and then concentrated under reduced
pressure. Analysis by 1H NMR spectroscopy indicated this to be mixture of Z-2-butendial, 28, (±)-29 and (±)-30 in
a ratio of 2 : 1.5 : 1 : 3. Z-2-Butendial was identified by comparison to the literature spectral data.15 The residue
was purified by column chromatography (SiO2, hexane–ethyl acetate gradient 10 : 1 to 1 : 4) to give 28 (8 mg,
24%) as a colorless solid, followed by (±)-29 (7 mg, 14%) as a colorless oil, and finally (±)-30 (14 mg, 29%) as a
colorless solid.

N-Vinylphthalimide28
mp 84–86 °C (lit.19 mp 83–86 °C); δH (300 MHz, CDCl3) 5.06 (1H, d, J = 10.3, H-2trans), 6.10 (1H, d, J = 16.3, H-2cis),
6.89 (1H, dd, J = 9.9 and 16.5, H-1), 7.73–7.79 and 7.86–7.91 (4H total, AA′BB′, Phth); δC (75 MHz, CDCl3) 104.8,
123.9, 124.0, 131.8, 134.7, 166.7.

Oxetane (±)-29

δH (400 MHz, CDCl3) 3.04 (1H, td, J = 8.0 and 12.0, H-2), 3.82 (1H, ddd, J = 4.6, 7.6 and 12.0, H-2′), 6.07 (1H,
dd, J = 7.2 and 11.6, H-5), 6.33 (1H, q, J = 7.2, H-3), 6.40 (1H, ddd, J = 1.2, 5.0 and 8.3, H-1), 6.88 (1H, ddd, J = 0.8,
6.8 and 11.5, H-4), 7.78–7.80 (2H, m, Phth), 7.92–7.94 (2H, m, Phth), 10.15 (1H, d, J = 7.2, CHO); δC (75 MHz,
CDCl3) 33.8 (C-2), 74.9, 77.8 (C-1 and C-3), 123.9 (Phth), 129.8 (C-5), 131.9, 134.9 (2 × Phth), 150.5 (C-4), 167.4
(N–C O), 191.3 (CHO). FAB-HRMS calcd for C14H11NO4 (M+H+) 258.0766, found 258.0766.

N-(2,4-Cyclohexadien-1-yl)phthalimide bisepoxide (±)-30

(Found: C, 65.15; H, 4.36. Calcd for C14H11NO4: C, 65.36; H, 4.36); mp 205–207 °C; δH (400 MHz, CDCl3) 2.13 (1H,
ddd, J = 2.6, 6.6 and 15.0, H-6), 2.40 (1H, ddd, J = 2.4, 9.2 and 14.8, H-6′), 3.26 (1H, dd, J = 2.6 and 3.8), 3.30 (1H,
td, J = 2.4 and 4.0), 3.54–3.56 (1H, m), 3.58–3.60 (1H, m), 4.59 (1H, ddd, J = 2.4, 6.8 and 9.4, H-1), 7.75–7.77 (2H,
AA′BB′, Phth), 7.86–7.88 (2H, AA′BB′, Phth); δC (75 MHz, CDCl3) 26.0 (C-6), 43.5, 47.3, 49.3, 49.7, 50.7, 123.7,
131.9, 134.6 (3 × Phth), 168.0 (N–C O).

N-(2,3-Epoxy-4R*,5S*-dihydroxycyclohex-1R*-yl)phthalimide (±)-33

To a stirring solution of 9 (150 mg, 0.584 mmol) in dry CH2Cl2 (5 mL) at room temperature was added Grubbs'
second generation catalyst (50 mg, 10 mol%). The mixture was stirred for 30 min and then concentrated under
reduced pressure and applied to a column of silica (prepared with hexanes). The column was eluted (hexane–
ethyl acetate = 4 : 1); however, before any material exited the column the solvent flow was stopped and left to
stand overnight. After 12 h continued elution (ethyl acetate), gave (±)-33 as a colorless solid (40 mg, 26%). mp
215–218 °C; δH (400 MHz, CD3OD) 1.81–1.91 (1H, m, H-6eq), 1.98 (1H, q, J = 12.0, H-6ax), 3.38 (1H, dd, J = 1.5 and
3.6), 3.45 (1H, dd, J = 1.5 and 3.6), 3.64 (1H, ddd, J = 3.6, 8.4 and 12.0, H-5), 3.87 (1H, dd, J = 1.5 and 8.5, H-4),
4.58 (1H, dd, J = 6.9 and 11.4, H-1), 7.78–7.90 (4H, m, Phth); δC (75 MHz, CH3OD) δ 35.3, 46.6, 58.8, 59.8, 68.3,
74.8, 124.4, 133.3, 135.8 (Phth), 169.1 (N–C O); FAB-HRMS calcd for C14H14NO5 (M+H+) 276.0872, found
276.0875.

N-(3,4-Epoxy-2S*,5R*-dihydroxycyclohex-1R*-yl)phthalimide (±)-34

To a stirring solution of (±)-14 (50.0 mg, 0.193 mmol) in CH2Cl2 (1 mL) was added a solution of mCPBA (0.1 g, ∼70
wt%, ∼0.4 mmol) in CH2Cl2 (1 mL). The reaction mixture was stirred for 7 h and then quenched with 10%
aqueous NEt3 (10 mL). The resulting mixture was extracted several times with ethyl acetate and the combined
extracts washed with brine, dried (Na2SO4) and concentrated. The crude product was purified by column
chromatography (SiO2, ethyl acetate) to give (±)-34 (22.0 mg, 42%) as a colorless solid. (Found: C, 60.58; H, 4.80.
Calcd for C14H13NO5·0.1H2O: C, 60.69; H, 4.80); mp 203–206 °C; δH (400 MHz, CD3OD) 1.68 (1H, br d, J = 14.0, H6eq), 2.52 (1H, ddd, J = 6.0, 12.4 and 14.4, H-6ax), 3.47–3.49 (2H, narrow m, H-3 & H-4), 4.25–4.29 (1H, m, H-5),
4.52 (1H, ddd, J = 3.2, 9.6 and 13.0, H-1), 4.66 (1H, d, J = 9.2, H-2), 7.78–7.89 (4H, m, Phth); δC (100 MHz, CD3OD)
36.1 (C-6), 48.8 (C-1), 57.3, 59.0, 64.9, 68.6 (C-2, C-3, C-4, C-5), 124.1, 133.4, 135.5 (3 × Phth), 170.1 (N–C O).

N-(2,3-Epoxy-4R*,5R*-dihydroxycyclohex-1R*-yl)phthalimide (±)-35

The epoxidation of (±)-17 (100 mg, 0.400 mmol) with mCPBA (0.2 g, 0.8 mmol) was carried out in a fashion
similar to the epoxidation of 27, except that the reaction was stirred for 12 h. The resulting mixture was
extracted several times with CH2Cl2, and the combined extracts were washed with brine, dried (Na2SO4) and
concentrated. The excess Et3N was removed under high vacuum to give (±)-35 (73 mg, 70%) as a colorless solid
(Found: C, 59.95; H, 4.69. Calcd for C14H13NO5·¼H2O: C, 60.10; H, 4.86); mp 167–170 °C; δH (400 MHz, CDCl3) 2.03
(1H, ddd, J = 2.0, 10.7 and 13.7, H-6ax), 2.25 (1H, dddd, J = 1.6, 4.2, 6.9 and 13.7, H-6eq), 2.89 (1H, d, J = 11.6, OH),
3.05 (1H, d, J = 10.0, OH), 3.48 (1H, dd, J = 1.6 and 3.6), 3.65–3.68 (1H, narrow m), 3.97–4.25 (1H, m, H-4), 4.19
(1H, ddd, J = 1.6, 4.3 and 9.5, H-5), 4.88 (1H, dd, J = 6.9 and 10.6, H-1), 7.75–7.80 and 7.85–7.89 (4H total,
AA′BB′, Phth); δC (100 MHz, CDCl3) 32.3 (C-6), 41.7 (C-1), 58.7, 58.9, 67.2, 68.4 (C-2, C-3, C-4 and C-5), 123.8,
131.9, 134.7 (3 × Phth), 167.8 (N–C O).

Hydrolysis of epoxydiol33

To a solution of (±)-33 (65 mg, 0.236 mmoL) in water (3 mL) was added concentrated H2SO4 (6 drops). The
suspension was heated at reflux, after 30 min all of the material dissolved, and after an additional 20 min a
colorless solid began to precipitate. The mixture was heated for a total of 70 min, cooled to room temperature
and concentrated under reduced pressure. The concentrated syrup was adsorbed to a small amount of silica gel
and this was applied to the top of a column of silica. Elution (ethyl acetate) gave (±)-24 as a colorless solid (48
mg, 74%). The mp and 1H NMR spectral data for this material was identical to that previously obtained.

N-(2R*,3S*,4R*,5R*-Tetraacetoxycyclohex-1R*-yl)phthalimide (±)-36

To a suspension of epoxide35 (137 mg, 0.498 mmol) in water (10 mL) was added 70% aqueous HClO4 (6 drops)
and the suspension was heated at reflux. After 20 min of heating the suspension turned clear and after a further
30 min a colorless solid compound began to separate from solution. The mixture was heated for an additional 20
min (total 70 min), cooled to room temperature, filtered, and the residue dried under high vacuum to afford a
crude tetraol (86 mg); mp 265–267 °C. A sample of the crude tetraol (70 mg, 0.24 mmol) in acetic anhydride
(0.20 mL) and pyridine (0.15 mL) was stirred for 18 h. During this time the undissolved material went into
solution. The reaction mixture was diluted with ethyl acetate (5 mL) and quenched with 1 M aqueous HCl (10
mL) and the resulting mixture was extracted twice with ethyl acetate. The combined extracts were washed with
brine, dried (Na2SO4) and concentrated. The residue was purified by column chromatography (SiO2, hexane–
ethyl acetate = 1 : 1) to afford (±)-36 as a colorless solid (79 mg, 42% overall). (Found: C, 57.15; H, 5.04. Calcd for
C22H23NO10: C, 57.26; H, 5.04); mp 67–70 °C; δH (400 MHz, CDCl3) 2.02, 2.06, 2.11, 2.17 (13H, 4xs and m, H-6eq &
OAc), 3.18 (1H, br t, J = 11.0, H-6ax), 5.04 (1H, ddd, J = 3.3, 4.5 and 11.1, H-1), 5.31–5.36 (1H, narrow m), 5.38–
5.43 (2H, narrow m), 5.64–5.70 (1H, m, H-5), 7.70–7.86 (4H, m, Phth); δC (75 MHz, CDCl3) 20.95, 21.0, 21.2 (2
×CH3CO2), 27.4 (C-6), 44.8 (C-1), 67.9, 68.2, 69.3, 70.0 (C-2, C-3, C-4, C-5), 123.6, 131.7, 134.5 (3 × Phth), 168.7,
170.1, 170.2 (3 × C O).

Hydrolysis/acetylation of epoxide (+)-34

The hydrolysis/acetylation of epoxide34 (160 mg, 0.582 mmol) in water (7 mL) was carried out in a fashion
similar to that for the hydrolysis of 35, except that concentrated H2SO4 (14 drops) was used as acid instead of
HClO4. The crude tetraol mixture was peracetylated (Ac2O/pyr) in a fashion similar to the preparation of 36.
Purification of the residue by column chromatography (SiO2, hexane–ethyl acetate = 1 : 1) gave a colorless solid
(137 mg, 51% overall). Analysis of the 1H NMR of this product indicated that it consisted of a mixture of
diastereomers (∼2 : 1). Slow recrystallization of the mixture (ethyl acetate) gave (±)-37 as long rectangular
crystals and (±)-38 as more cubic crystals. These were manually separated (tweezers) to afford the pure
diastereomers.

N-(2S*,3R*,4R*,5R*-Tetraacetoxycyclohex-1R*-yl)phthalimide (±)-37

(Found: C, 57.18; H, 4.96. Calcd for C22H23NO10: C, 57.26; H, 5.04); mp 215–217 °C; δH (300 MHz, CDCl3) 1.85,
2.02, 2.21 (13H, 4×s and m, H-6eq and OAc), 2.93 (1H, dt, J = 2.1 and 14.0, H-6ax), 4.70 (1H, ddd, J = 4.8, 10.5 and
13.2, H-1), 5.11 (1H, dd, J = 2.8 and 10.7, H-4), 5.51–5.58 (2H, m, H-3 and H-5), 5.73 (1H, dd, J = 9.6 and 10.5, H2), 7.70–7.88 (4H, m, Phth); δC (75 MHz, CDCl3) 20.6, 20.8, 20.7, 21.3 (4 ×CH3CO2), 28.7 (C-6), 47.4 (C-1), 67.5,
70.4, 71.6, 71.7 (C-2, C-3, C-4, C-5), 123.8, 131.6, 134.6 (3 × Phth), 168.0, 170.0, 170.1, 170.15, 170.17 (5 × C O).

N-(2S*,3S*,4S*,5R*-Tetraacetoxycyclohex-1R*-yl)phthalimide (±)-38

(Found: C, 57.17; H, 4.98. Calcd for C22H23NO10: C, 57.26; H, 5.04); mp 218-221 °C; δH (300 MHz, CDCl3) 1.85 (3H,
s, OAc), 2.00–2.13 (1H, br d, J = 14.4, H-6eq), 2.15, 2.17, 2.21 (9H, 3×s, OAc), 2.99 (1H, ddd, J = 3.6, 12.5 and 14.4,
H-6ax), 4.92 (1H, ddd, J = 4.2, 10.9 and 12.2, H-1), 5.10–5.13 (1H, narrow m), 5.16 (1H, dt, J = 1.5 and 3.0), 5.48
(1H, dt, J = 1.2 and 3.5, H-5), 5.87 (1H, dd, J = 3.6 and 10.8, H-2), 7.73–7.90 (4H, m, Phth); δC (75 MHz, CDCl3)

20.8, 21.0, 21.1, 21.2 (4 ×CH3CO2), 29.2 (C-6), 44.5 (C-1), 68.1, 68.6, 68.7, 69.0 (C-2, C-3, C-4, C-5), 123.7, 131.7,
134.5 (3 × Phth), 168.2, 169.0, 169.7, 169.74, 169.9 (5 × C O).
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Footnotes

1. † Electronic supplementary information (ESI) available: Copies of 1H and 13C NMR spectra of new
compounds and ORTEPs for 9, 10, 18, 33, 34, and 35. CCDC reference numbers 767841, 767844–767848.
For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c004730a

2. ‡ The cif files for 9, 10, 18, 33, 34, and 35 have been deposited with the CCDC.†9: CCDC # 767847; 10:
CCDC # 767848; 18: CCDC # 767846; 25a: CCDC # 767841; 33: CCDC # 768802; 34: CCDC # 767845; 35:
CCDC # 767844. The crystal structures for 26, 33 and 34 are all heavily disordered. The nature of the
disorder is that the H-bonding networks have a quasi-mirror symmetry and thus can accommodate both
enantiomers. These three crystals are centrosymmetric, so they are racemates on the macro level;
however, on the micro level, the two enantiomeric forms randomly substitute each other in H-bonded
networks. Crystal structure data for compound (±)-26: C14H15NO6; M = 293.27; monoclinic, P21/n; a =
12.0696(6), b = 6.9279(4), c = 15.8178(8) Å, β = 108.536(2)°; U = 1254.02(11) Å3; T = 100(2) K; Z = 4;
10253 reflections measured, 2215 unique (Rint = 0.0278). The final wR2 was 0.2512 (all data). CCDC #
768801. Crystal structure data for compound (±)-25a: C22H23NO10; M = 461.41; monoclinic, C2/c; a =
27.7646(12), b = 11.6104(5), c = 16.3768(7) Å, β = 123.535(2)°; U = 4400.5(3) Å3; T = 100(2) K; Z = 8;
17563 reflections measured, 3843 unique (Rint = 0.0431). The final wR2 was 0.1035 (all data). CCDC
# 767841. Crystal structure data for compound (±)-37: C22H23NO10; M = 461.41; monoclinic, P21/n; a =
8.8800(3), b = 10.6102(3), c = 23.7595(8) Å, β = 91.799(2)°; U = 2237.48(12) Å3; T = 100(2) K; Z = 4; 18364
reflections measured, 3972 unique (Rint = 0.0193). The final wR2 was 0.0839 (all data). CCDC # 767842.
Crystal structure data for compound (±)-38: C22H23NO10; M = 461.41; monoclinic, P21/c; a =
7.3527(2), b = 21.4079(7), c = 14.1359(5) Å, β = 93.921(2)°; U = 2219.87(12) Å3; T = 100(2) K; Z = 4; 17338
reflections measured, 3890 unique (Rint = 0.0265). The final wR2 was 0.1019 (all data). CCDC # 767843.

